BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 28913878)

  • 1. Do pancreatic cancer and chronic pancreatitis share the same genetic risk factors? A PANcreatic Disease ReseArch (PANDoRA) consortium investigation.
    Campa D; Pastore M; Capurso G; Hackert T; Di Leo M; Izbicki JR; Khaw KT; Gioffreda D; Kupcinskas J; Pasquali C; Macinga P; Kaaks R; Stigliano S; Peeters PH; Key TJ; Talar-Wojnarowska R; Vodicka P; Valente R; Vashist YK; Salvia R; Papaconstantinou I; Shimizu Y; Valsuani C; Zambon CF; Gazouli M; Valantiene I; Niesen W; Mohelnikova-Duchonova B; Hara K; Soucek P; Malecka-Panas E; Bueno-de-Mesquita HBA; Johnson T; Brenner H; Tavano F; Fogar P; Ito H; Sperti C; Butterbach K; Latiano A; Andriulli A; Cavestro GM; Busch ORC; Dijk F; Greenhalf W; Matsuo K; Lombardo C; Strobel O; König AK; Cuk K; Strothmann H; Katzke V; Cantore M; Mambrini A; Oliverius M; Pezzilli R; Landi S; Canzian F
    Int J Cancer; 2018 Jan; 142(2):290-296. PubMed ID: 28913878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of PRSS1-PRSS2 rs10273639, CLDN2 rs7057398 and MORC4 rs12688220 polymorphisms on individual susceptibility to pancreatitis: A meta-analysis.
    Deng Y; Li Z
    Genomics; 2020 Jan; 112(1):848-852. PubMed ID: 31163246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymorphisms at PRSS1-PRSS2 and CLDN2-MORC4 loci associate with alcoholic and non-alcoholic chronic pancreatitis in a European replication study.
    Derikx MH; Kovacs P; Scholz M; Masson E; Chen JM; Ruffert C; Lichtner P; Te Morsche RH; Cavestro GM; Férec C; Drenth JP; Witt H; Rosendahl J;
    Gut; 2015 Sep; 64(9):1426-33. PubMed ID: 25253127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of pancreatic juice proteins as biomarkers of pancreatic cancer.
    Gao J; Zhu F; Lv S; Li Z; Ling Z; Gong Y; Jie C; Ma L
    Oncol Rep; 2010 Jun; 23(6):1683-92. PubMed ID: 20428826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association Analysis of PRSS1-PRSS2 and CLDN2-MORC4 Variants in Nonalcoholic Chronic Pancreatitis Using Tropical Calcific Pancreatitis as Model.
    Paliwal S; Bhaskar S; Nageshwar Reddy D; Rao GV; Thomas V; Singh SP; Chandak GR
    Pancreas; 2016 Sep; 45(8):1153-7. PubMed ID: 26784911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of claudin2 and PRSS1-PRSS2 polymorphisms with idiopathic recurrent acute and chronic pancreatitis: A case-control study from India.
    Avanthi SU; Ravi Kanth VV; Agarwal J; Lakhtakia S; Gangineni K; Rao GV; Reddy DN; Talukdar R
    J Gastroenterol Hepatol; 2015 Dec; 30(12):1796-801. PubMed ID: 26110235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genome-Wide Association Study Data Reveal Genetic Susceptibility to Chronic Inflammatory Intestinal Diseases and Pancreatic Ductal Adenocarcinoma Risk.
    Yuan F; Hung RJ; Walsh N; Zhang H; Platz EA; Wheeler W; Song L; Arslan AA; Beane Freeman LE; Bracci P; Canzian F; Du M; Gallinger S; Giles GG; Goodman PJ; Kooperberg C; Le Marchand L; Neale RE; Rosendahl J; Scelo G; Shu XO; Visvanathan K; White E; Zheng W; Albanes D; Amiano P; Andreotti G; Babic A; Bamlet WR; Berndt SI; Brennan P; Bueno-de-Mesquita B; Buring JE; Campbell PT; Chanock SJ; Fuchs CS; Gaziano JM; Goggins MG; Hackert T; Hartge P; Hassan MM; Holly EA; Hoover RN; Katzke V; Kirsten H; Kurtz RC; Lee IM; Malats N; Milne RL; Murphy N; Ng K; Oberg AL; Porta M; Rabe KG; Real FX; Rothman N; Sesso HD; Silverman DT; Thompson IM; Wactawski-Wende J; Wang X; Wentzensen N; Wilkens LR; Yu H; Zeleniuch-Jacquotte A; Shi J; Duell EJ; Amundadottir LT; Li D; Petersen GM; Wolpin BM; Risch HA; Yu K; Klein AP; Stolzenberg-Solomon R
    Cancer Res; 2020 Sep; 80(18):4004-4013. PubMed ID: 32641412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Common Variants in CLDN2 and MORC4 Genes Confer Disease Susceptibility in Patients with Chronic Pancreatitis.
    Giri AK; Midha S; Banerjee P; Agrawal A; Mehdi SJ; Dhingra R; Kaur I; G RK; Lakhotia R; Ghosh S; Das K; Mohindra S; Rana S; Bhasin DK; Garg PK; Bharadwaj D;
    PLoS One; 2016; 11(1):e0147345. PubMed ID: 26820620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic variability of the ABCC2 gene and clinical outcomes in pancreatic cancer patients.
    Gentiluomo M; Puchalt García P; Galeotti AA; Talar-Wojnarowska R; Tjaden C; Tavano F; Strobel O; Kupcinskas J; Neoptolemos J; Hegyi P; Costello E; Pezzilli R; Sperti C; Lawlor RT; Capurso G; Szentesi A; Soucek P; Vodicka P; Lovecek M; Hackert T; Cavestro GM; Milanetto AC; Canzian F; Campa D
    Carcinogenesis; 2019 Jun; 40(4):544-550. PubMed ID: 30629142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Panel of serum miRNAs as potential non-invasive biomarkers for pancreatic ductal adenocarcinoma.
    Khan IA; Rashid S; Singh N; Rashid S; Singh V; Gunjan D; Das P; Dash NR; Pandey RM; Chauhan SS; Gupta S; Saraya A
    Sci Rep; 2021 Feb; 11(1):2824. PubMed ID: 33531550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood small extracellular vesicles derived miRNAs to differentiate pancreatic ductal adenocarcinoma from chronic pancreatitis.
    Guo S; Qin H; Liu K; Wang H; Bai S; Liu S; Shao Z; Zhang Y; Song B; Xu X; Shen J; Zeng P; Shi X; Chen H; Gao S; Xu J; Pan Y; Xiong L; Li F; Zhang D; Jiao X; Jin G
    Clin Transl Med; 2021 Sep; 11(9):e520. PubMed ID: 34586739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pancreatic Juice Exosomal MicroRNAs as Biomarkers for Detection of Pancreatic Ductal Adenocarcinoma.
    Nakamura S; Sadakari Y; Ohtsuka T; Okayama T; Nakashima Y; Gotoh Y; Saeki K; Mori Y; Nakata K; Miyasaka Y; Onishi H; Oda Y; Goggins M; Nakamura M
    Ann Surg Oncol; 2019 Jul; 26(7):2104-2111. PubMed ID: 30820789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of replication of seven pancreatic cancer susceptibility loci identified in two Asian populations.
    Campa D; Rizzato C; Bauer AS; Werner J; Capurso G; Costello E; Talar-Wojnarowska R; Jamroziak K; Pezzilli R; Gazouli M; Khaw KT; Key TJ; Bambi F; Mohelnikova-Duchonova B; Heller A; Landi S; Vodickova L; Theodoropoulos G; Bugert P; Vodicka P; Hoheisel JD; Delle Fave G; Neoptolemos JP; Soucek P; Büchler MW; Giese N; Canzian F
    Cancer Epidemiol Biomarkers Prev; 2013 Feb; 22(2):320-3. PubMed ID: 23250936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated miR-483-3p expression is an early event and indicates poor prognosis in pancreatic ductal adenocarcinoma.
    Wang C; Sun Y; Wu H; Yu S; Zhang L; Meng Y; Liu M; Yang H; Liu P; Mao X; Lu Z; Chen J
    Tumour Biol; 2015 Dec; 36(12):9447-56. PubMed ID: 26124009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utilization of CDX2 expression in diagnosing pancreatic ductal adenocarcinoma and predicting prognosis.
    Xiao W; Hong H; Awadallah A; Zhou L; Xin W
    PLoS One; 2014; 9(1):e86853. PubMed ID: 24489794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Annexin A10 is a candidate marker associated with the progression of pancreatic precursor lesions to adenocarcinoma.
    Zhu J; Wu J; Pei X; Tan Z; Shi J; Lubman DM
    PLoS One; 2017; 12(4):e0175039. PubMed ID: 28369074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased CDC20 expression is associated with pancreatic ductal adenocarcinoma differentiation and progression.
    Chang DZ; Ma Y; Ji B; Liu Y; Hwu P; Abbruzzese JL; Logsdon C; Wang H
    J Hematol Oncol; 2012 Apr; 5():15. PubMed ID: 22475564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single nucleotide polymorphism in the microRNA-199a binding site of HIF1A gene is associated with pancreatic ductal adenocarcinoma risk and worse clinical outcomes.
    Wang X; Ren H; Zhao T; Ma W; Dong J; Zhang S; Xin W; Yang S; Jia L; Hao J
    Oncotarget; 2016 Mar; 7(12):13717-29. PubMed ID: 26872370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PRSS1 intron mutations in patients with pancreatic cancer and chronic pancreatitis.
    Gao F; Liu QC; Zhang S; Zhuang ZH; Lin CZ; Lin XH
    Mol Med Rep; 2012 Feb; 5(2):449-51. PubMed ID: 22109105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of genetic polymorphisms with survival of pancreatic ductal adenocarcinoma patients.
    Rizzato C; Campa D; Talar-Wojnarowska R; Halloran C; Kupcinskas J; Butturini G; Mohelníková-Duchoňová B; Sperti C; Tjaden C; Ghaneh P; Hackert T; Funel N; Giese N; Tavano F; Pezzilli R; Pedata M; Pasquali C; Gazouli M; Mambrini A; Souček P; di Sebastiano P; Capurso G; Cantore M; Oliverius M; Offringa R; Małecka-Panas E; Strobel O; Scarpa A; Canzian F
    Carcinogenesis; 2016 Oct; 37(10):957-64. PubMed ID: 27497070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.